Today's Hours: 8:00am - 6:00pm

Search

Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    edited by Alan F. Schatzberg, Charles B. Nemeroff.
    Summary: "The American Psychiatric Association Publishing Textbook of Psychopharmacology is an indispensable and comprehensive resource for clinicians and trainees who prescribe psychotropic medications. Updated to reflect the new DSM-5 classification, this revised Fifth Edition maintains the user-friendly structure of its predecessors while offering in-depth coverage of the latest research in pharmacological principles, classes of drugs, and psychiatric disorders. Introductory chapters provide a theoretical grounding in clinical applications, with topics ranging from neurotransmitters to brain imaging in psychopharmacology. The bulk of the book is devoted to various classes of drugs, including antidepressants, anxiolytics, antipsychotics, mood stabilizers, and other agents, with each class divided into chapters on specific drugs -- either new or revised to include the latest findings and trends. Finally, the section on psychopharmacological treatment addresses evidence-based principles of clinical care for the full spectrum of mental disorders and conditions -- from depression to chronic pain -- as well as for specific populations and circumstances -- from children and adolescents to psychiatric emergencies -- offering information on topics such as medication selection, combination and maintenance dosing regimens, monitoring and management of side effects, and strategies for optimizing treatment response. The book's beneficial features are many: * The section on principles of pharmacology has been revised and reorganized to incorporate recent discoveries from the fields of neurobiology, genetics, brain imaging, and epidemiology.* History and discovery, structure--activity relationships, pharmacological profiles, pharmacokinetics and disposition, mechanisms of action, indications and efficacy, side effects and toxicology, and drug--drug interactions are addressed for each agent. This consistent structure places the desired information at the clinician's fingertips and facilitates study for trainees.* Coverage of drugs approved since the last edition is thorough, encompassing new antidepressants (e.g., vortioxetine), new antipsychotics (e.g., cariprazine), and agents on the clinical horizon (e.g., ketamine).* More than 180 tables and graphs present critically important data in an accessible way. A work of uncommon scientific rigor and clinical utility, The American Psychiatric Association Publishing Textbook of Psychopharmacology provides state-of-the-art information on both the principles and the practice of psychopharmacological treatment of psychiatric disorders."--Publisher's description.

    Contents:
    Part I: Principles of pharmacology. Basic principles of molecular biology and genomics
    Neurotransmitters and receptors in psychiatric disorders
    Genetics and genomics
    Psychoneuroendocrinology
    Brain–immune system interactions
    Principles of pharmacokinetics and pharmacodynamics
    Brain imaging in psychopharmacology
    Part II: Classes of psychiatric treatments: antidepressants and anxiolytics. Monoamine oxidase inhibitors
    Tricyclic and tetracyclic drugs
    Fluoxetine
    Sertraline
    Paroxetine
    Fluvoxamine
    Citalopram and escitalopram
    Trazodone and nefazodone
    Vortioxetine
    Mirtazapine
    Bupropion
    Venlafaxine and desvenlafaxine
    Duloxetine, milnacipran, and levomilnacipran
    Ketamine
    Benzodiazepines
    Buspirone
    Antipsychotics. Classic antipsychotic medications
    Clozapine
    Olanzapine
    Quetiapine
    Risperidone and paliperidone
    Aripiprazole and brexpiprazole
    Ziprasidone
    Asenapine
    Iloperidone
    Lurasidone
    Cariprazine
    Drugs to treat extrapyramidal side effects
    Drugs for treatment of bipolar disorder. Lithium
    Valproate
    Carbamazepine, oxcarbazepine, and licarbazepine
    Gabapentin and pregabalin
    Lamotrigine
    Topiramate
    Other agents. Agents for cognitive disorders
    Sedative-hypnotics
    Psychostimulants and wakefulness-promoting agents
    Electroconvulsive therapy and other neuromodulation therapies
    Part III: Psychopharmacological treatment. Treatment of depression
    Treatment of bipolar disorder
    Treatment of anxiety and related disorders
    Treatment of schizophrenia
    Treatment of substance-related disorders
    Treatment of personality disorders
    Treatment of eating disorders
    Treatment of insomnia
    Treatment of chronic pain
    Treatment of child and adolescent disorders
    Treatment during late life
    Psychopharmacology during pregnancy and lactation
    Treatment of psychiatric emergencies
    Treatment of agitation and aggression in the elderly
    Digital Access PsychiatryOnline 2017
  • Book
    edited by Alan F. Schatzberg, Charles B. Nemeroff.
    Summary: "The American Psychiatric Association Publishing Textbook of Psychopharmacology is an indispensable and comprehensive resource for clinicians and trainees who prescribe psychotropic medications. Updated to reflect the new DSM-5 classification, this revised Fifth Edition maintains the user-friendly structure of its predecessors while offering in-depth coverage of the latest research in pharmacological principles, classes of drugs, and psychiatric disorders. Introductory chapters provide a theoretical grounding in clinical applications, with topics ranging from neurotransmitters to brain imaging in psychopharmacology. The bulk of the book is devoted to various classes of drugs, including antidepressants, anxiolytics, antipsychotics, mood stabilizers, and other agents, with each class divided into chapters on specific drugs -- either new or revised to include the latest findings and trends. Finally, the section on psychopharmacological treatment addresses evidence-based principles of clinical care for the full spectrum of mental disorders and conditions -- from depression to chronic pain -- as well as for specific populations and circumstances -- from children and adolescents to psychiatric emergencies -- offering information on topics such as medication selection, combination and maintenance dosing regimens, monitoring and management of side effects, and strategies for optimizing treatment response. The book's beneficial features are many: * The section on principles of pharmacology has been revised and reorganized to incorporate recent discoveries from the fields of neurobiology, genetics, brain imaging, and epidemiology.* History and discovery, structure--activity relationships, pharmacological profiles, pharmacokinetics and disposition, mechanisms of action, indications and efficacy, side effects and toxicology, and drug--drug interactions are addressed for each agent. This consistent structure places the desired information at the clinician's fingertips and facilitates study for trainees.* Coverage of drugs approved since the last edition is thorough, encompassing new antidepressants (e.g., vortioxetine), new antipsychotics (e.g., cariprazine), and agents on the clinical horizon (e.g., ketamine).* More than 180 tables and graphs present critically important data in an accessible way. A work of uncommon scientific rigor and clinical utility, The American Psychiatric Association Publishing Textbook of Psychopharmacology provides state-of-the-art information on both the principles and the practice of psychopharmacological treatment of psychiatric disorders."--Publisher's description.

    Contents:
    Part I: Principles of pharmacology. Basic principles of molecular biology and genomics
    Neurotransmitters and receptors in psychiatric disorders
    Genetics and genomics
    Psychoneuroendocrinology
    Brain–immune system interactions
    Principles of pharmacokinetics and pharmacodynamics
    Brain imaging in psychopharmacology
    Part II: Classes of psychiatric treatments: antidepressants and anxiolytics. Monoamine oxidase inhibitors
    Tricyclic and tetracyclic drugs
    Fluoxetine
    Sertraline
    Paroxetine
    Fluvoxamine
    Citalopram and escitalopram
    Trazodone and nefazodone
    Vortioxetine
    Mirtazapine
    Bupropion
    Venlafaxine and desvenlafaxine
    Duloxetine, milnacipran, and levomilnacipran
    Ketamine
    Benzodiazepines
    Buspirone
    Antipsychotics. Classic antipsychotic medications
    Clozapine
    Olanzapine
    Quetiapine
    Risperidone and paliperidone
    Aripiprazole and brexpiprazole
    Ziprasidone
    Asenapine
    Iloperidone
    Lurasidone
    Cariprazine
    Drugs to treat extrapyramidal side effects
    Drugs for treatment of bipolar disorder. Lithium
    Valproate
    Carbamazepine, oxcarbazepine, and licarbazepine
    Gabapentin and pregabalin
    Lamotrigine
    Topiramate
    Other agents. Agents for cognitive disorders
    Sedative-hypnotics
    Psychostimulants and wakefulness-promoting agents
    Electroconvulsive therapy and other neuromodulation therapies
    Part III: Psychopharmacological treatment. Treatment of depression
    Treatment of bipolar disorder
    Treatment of anxiety and related disorders
    Treatment of schizophrenia
    Treatment of substance-related disorders
    Treatment of personality disorders
    Treatment of eating disorders
    Treatment of insomnia
    Treatment of chronic pain
    Treatment of child and adolescent disorders
    Treatment during late life
    Psychopharmacology during pregnancy and lactation
    Treatment of psychiatric emergencies
    Treatment of agitation and aggression in the elderly
    Digital Access PsychiatryOnline 2017